Female Infertility Diagnosis & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- In Vitro Diagnostics
Infertility is the inability of a person to reproduce naturally. Female infertility is the inability of a woman to become pregnant and carry pregnancy to full term. It is the most common issue faced by couples trying to get conceived. The most commonly diagnosed causes of female infertility are issues with ovulation; hormonal imbalance; anatomical disorders of the reproductive system such as damage caused to the fallopian tubes, the uterus, or the cervix; overuse of alcohol or drugs; thyroid gland-associated issues; excessive weight; and stress. Growing prevalence of polycystic ovarian syndrome (PCOS) and other hormonal disorders, changing lifestyle, obesity, and increasing awareness about advanced fertility techniques are some of the factors expected to boost the global fertility diagnosis & treatment market during the forecast period. However, high cost of treatments, possibility of failure, and shortage of skilled medical professionals in developing countries are expected to restrain the global female infertility diagnosis & treatment market between 2017 and 2025.
The global female infertility diagnosis & treatment market can be segmented based on diagnosis type, treatment type, end-user, and region. In terms of diagnosis type, the market has been segmented into ovulation testing, blood & urine testing to confirm presence of infection or imbalance in thyroid hormone level, hysterosalpingography, ovarian reserve testing, imaging tests, laparoscopy, genetic testing, and other hormone testing. In terms of treatment type, the global female infertility diagnosis & treatment market can be categorized into fertility restoration therapy and reproductive assistance therapy. The fertility restoration therapy segment can be sub-segmented based on drug type and surgery type. In terms of drug type, the segment can be divided into clomiphene citrate, gonadotropins, metformin, letrozole, and bromocriptine. Based on surgery type, the fertility restoration therapy segment can be classified into laparoscopic or hysteroscopic surgery and tubal surgery. The reproductive assistance therapy segment can be further classified into intrauterine insemination (IUI) therapy, intracytoplasmic sperm injection (ICSI), gamete intrafallopian tube transfer, zygote intrafallopian transfer (ZIFT), gamete intrafallopian tube transfer (GIFT), and assisted reproductive technology (ART) or in-vitro fertilization (IVF). Based on end-user, the global female infertility diagnosis & treatment market can be divided into hospitals, specialty clinics, and pathological & diagnostic centers. The hospitals segment is expected to dominate the global market during the forecast period.
Geographically, the global female infertility diagnosis & treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected dominate the global market between 2017 and 2025, owing to increasing prevalence of hormonal disorders caused by changing lifestyle, excessive alcohol consumption, lack of exercise, and stress. According to a study by the University of Maryland Medical Center (UMMC), in the U.S., about 10% of women aged between 15 and 44 are having difficulties in getting pregnant or carrying the pregnancy to full term. Europe is the second-largest market for female infertility diagnosis & treatment, owing to growing research and development of novel fertility technologies and high awareness among couples about finding solutions for their infertility issues. According to the IVI, the largest assisted reproduction group in the world, in the Europe, the number of couples and individuals approaching medical practitioners for seeking advice to choose a suitable solution for infertility is increasing by around 9% every year. Asia Pacific is considered an emerging market for female infertility diagnosis & treatment, owing to increasing population, presence of developing economies, growing awareness about methods such as IVF and IUI, and increasing per capita health care spending in the region.
Key players operating in the global female infertility diagnosis & treatment market are Pfizer Inc. Sanofi, Janssen Global Services, LLC, Novartis AG, Par Pharmaceutical, Cook, Bayer AG, Bristol-Myers Squibb Company, Church & Dwight Co., Inc., CooperSurgical Inc., and EMD Serono, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from In Vitro Diagnostics
Medical DevicesNebulizers-Medical Devices Pipeline Product Landscape, 2021